Science Before Hype in MedTech Investing with Varun Turlapati of Chaanakya Capital | Ep. 69
Neurotech has one of the widest gaps in MedTech between public excitement and real scientific certainty. That makes diligence more important, not less. A compelling story, a futuristic device, or a category with massive upside can still lead investors in the wrong direction if the science is thin and the clinical case is not yet grounded.
That tension sits at the center of this episode. The strongest investment case is not built on how large the market sounds or how dramatic the pitch feels. It is built on whether the device is medically credible, whether the engineering holds up under pressure, and whether specialists who would actually use it believe it belongs in practice.
There is also a deeper lesson here for founders. In device categories where claims can run ahead of evidence, seriousness becomes a differentiator. Companies that think through regulatory fit, reimbursement logic, clinical use, and product hardening early are easier to believe, easier to diligence, and easier to support.
Cybersecurity fits directly into that same seriousness test. A connected device cannot be treated like a normal software startup where a broken feature can be patched without consequence. If security is deferred, the cost is not only financial. It can compromise product trust at the exact moment a company needs it most.
Episode Breakdown
00:00 The unknowns inside neurotech
00:31 Security decisions that should happen early
01:57 The fund’s early-stage focus
02:42 Science versus speculative claims
04:42 Valuation discipline at the seed stage
05:39 How power law logic applies in specialized VC
07:55 Why neurotech remains underbuilt
14:22 How founders are supported after investment
17:15 The missing cybersecurity layer
20:24 Why redesign gets expensive
22:17 Diligence beyond the usual checklist
24:20 How a small focused fund operates
29:45 Events, networks, and specialist insight
34:44 Multiples, IRR, and realistic return thinking
38:13 Final reflections
40:09 End
The Med Device Cyber Podcast is brought to you by Blue Goat Cyber, cybersecurity experts providing essential security solutions for the medical device industry. Learn more by visiting https://bluegoatcyber.com.
If you're interested in our services or partnering with us, schedule a Discovery Session: https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session
Christian Espinosa is the CEO and founder of Blue Goat Cyber. Trevor Slattery is the Chief Operating Officer at Blue Goat Cyber.
Christian Espinosa on LinkedIn: https://www.linkedin.com/in/christianespinosa/
Trevor Slattery on LinkedIn:
https://www.linkedin.com/in/trevor-slattery-34852b1a9
Blue Goat Cyber on LinkedIn: https://www.linkedin.com/company/blue-goat-cyber/
Blue Goat Cyber on Instagram: https://www.instagram.com/bluegoatcyber/
Blue Goat Cyber on Facebook: https://www.facebook.com/bluegoatcyber/
Blue Goat Cyber on YouTube: https://www.youtube.com/@BlueGoatCyber/?sub_confirmation=1
